Diabetes in pregnancy

Anticipated publication date:

Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period
In progress
Anticipated publication date
February 2015

NICE is developing four pieces of guidance relating to Diabetes over the next two years. Each piece of guidance will focus on a different element of the care pathway, Because of the breadth of advice that will be covered, it will not be possible for one centre to develop all four pieces of guidance. Therefore, the topics have been allocated as follows:

  1. Diabetes in Children (Type 1 and 2) – National Collaborating Centre for Women’s and Children’s Health
  2. Diabetes in Pregnancy – National Collaborating Centre for Women’s and Children’s Health
  3. Type 1 diabetes in adults – National Clinical Guidelines Centre
  4. Type 2 diabetes in adults – Internal Clinical Guideline Team - NICE

NICE has set up a steering committee to oversee the production of these pieces of guidance. This group, which will include development group members, guideline development group chairs, staff from all three guidance-producing centres and senior NICE staff will identify and act on any gaps or overlaps across the different guidance topics in order to ensure that the final guidance produced is complementary and consistent.

This page provides more detail on the Diabetes in pregnancy (update) clinical guideline. Please follow the links above to view details of the other pieces of guidance.

Provisional Schedule

Scoping workshop: 12 March 2012
Consultation on draft scope with stakeholders: 4 July - 29 Aug 2012
Consultation on draft guideline with stakeholders: 11 September - 23 October 2014
Publication date: February 2015

Project Team

Centre for clinical practice lead: Philip Alderson
Communications manager: Shalu Kanal
Guidelines commissioning manager:

Oliver Bailey

Guidelines coordinator: Besma Nash
Patient involvement lead: Emma Chambers
Implementation lead: Alexa Biesty
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.

Email enquiries


Key events during the development of the guidance

06 August 2014
The Health Economic plan, review questions and search strategies are now available to view on the website in preparation for the draft guideline consultation.
08 November 2012
The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The title of the guideline has also been amended in-line with the scope. The Guideline Development Group (GDG) oversees the development process.
4 September 2012
Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply. The National Collaborating Centre and the Institute are in the process of agreeing details of the workplan including how the development will progress, the membership of the Guideline Development Group and timescales.
4 July 2012
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
18 July 2011

The National Institute for Health and Clinical Excellence (NICE) has commissioned the National Clinical Guidelines Centre to update the clinical guideline on D, which was Diabetes in pregnancy, published by NICE in March 2008.

For further information regarding developing partial update guidelines please see the guidelines development manual 2009.

Get involved